CNBC Fast Money Halftime Report July 13, 2024
Moderna Coronavirus Vaccine trial. Youre said youre kouscautiousy optimistic tell us about your reflection on that data. There are various landmarks along the trial that could actually derail it at any given time the first that we saw was we went into a phase one trial very quickly, really with record speed. We did it with three doses and the first thing you look at is it safe . Clearly it was is it inducing the kind of response you would predict would be protected when the company and our investigators looked at the data in the first two doses of the phase one study in normal volunteers we fo...